3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Leukemia
5
Leukemia, Myeloid, Acute
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neuroblastoma
3
Sarcoma, Ewing
2
Rhabdomyosarcoma
2
Myelodysplastic Syndromes
2
Multiple Myeloma
2
Lymphoma
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Kidney Neoplasms
2
Congenital Abnormalities
2
Central Nervous System Neoplasms
2
Brain Neoplasms
2
Wilms Tumor
1
Thrombocythemia, Essential
1
Testicular Neoplasms
1
Teratoma
1
Sarcoma
1
Retinoblastoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Polycythemia Vera
1
Ovarian Neoplasms
1
Ovarian Germ Cell Cancer
1
Osteosarcoma
1
Neuroectodermal Tumors
1
Neoplasms, Plasma Cell
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Interventions
Ifosfamide
6
Leucovorin
5
Doxorubicin
4
Dexrazoxane
4
Cisplatin
4
Methotrexate
3
Filgrastim
3
Carboplatin
3
mifamurtide
2
glucarpidase
2
Radiotherapy
2
Neoadjuvant Therapy
2
Mesna
2
Granulocyte-Macrophage Colony-Stimulating Factor
2
Granulocyte Colony-Stimulating Factor
2
Gemcitabine
2
Cryosurgery
2
Chemotherapy, Adjuvant
2
temsirolimus
1
sintilimab
1
sargramostim
1
saracatinib
1
samarium Sm-153 lexidronam
1
robatumumab
1
pembrolizumab
1
pegfilgrastim
1
pazopanib
1
omburtamab I-131
1
niraparib
1
lexatumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Osteosarcoma
×
Bone Marrow Transplantation
×
Clear all
NCT02100891
2025-03-19
STIR
Medical College of Wisconsin
Phase 2
Terminated
15 enrolled
11 charts